NCT01480349 (SOPHH) is a clinical trial in Post-Hemorrhagic Hydrocephalus, sponsored by University of Utah.

Who is sponsoring NCT01480349?

NCT01480349 is sponsored by University of Utah.

What condition does NCT01480349 study?

NCT01480349 studies Post-Hemorrhagic Hydrocephalus.

Is NCT01480349 still recruiting?

NCT01480349 is currently completed. Last updated 26 December 2017.

Last reviewed 2017-12-26 · How we verify

NCT01480349: SOPHH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus

Completed Last updated 26 December 2017

What this trial tests

trial in Post-Hemorrhagic Hydrocephalus in 146 participants. Completed in 10 May 2016.

Timeline

10 January 2011

Primary endpoint
10 May 2016

10 May 2016

Quick facts

Lead sponsor	University of Utah
Status	Completed
Study type	OBSERVATIONAL
Enrollment	146
Start date	10 January 2011
Primary completion	10 May 2016
Estimated completion	10 May 2016
Sites	7 locations across Canada, United States

Conditions studied

Post-Hemorrhagic Hydrocephalus — all drugs for Post-Hemorrhagic Hydrocephalus →

Sponsor

University of Utah

Who can join

Under 180 Days, any sex, with Post-Hemorrhagic Hydrocephalus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multicenter, prospective pilot study will compare the effectiveness of two established procedures used in the treatment of post-hemorrhagic hydrocephalus in very low birth weight infants, specifically ventricular reservoirs and subgaleal shunts. The study is being conducted by the Hydrocephalus Clinical Research Network (HCRN), a network established to conduct multi-institutional clinical trials on pediatric hydrocephalus.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop.
Koschnitzky JE, Keep RF, Limbrick DD, McAllister JP, et al · · 2018 · cited 36× · PMID 29587767 · DOI 10.1186/s12987-018-0096-3
The Current State of Clinical Trials Studying Hydrocephalus: An Analysis of ClinicalTrials.gov.
Abraham ME, Povolotskiy R, Gold J, Ward M, et al · · 2020 · cited 3× · PMID 32983722 · DOI 10.7759/cureus.10029

Verify or expand the search:

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01480349 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 26 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01480349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing